Home < Scientific Library < Abstract < Acute Coronary Syndrom < 

Acute Coronary Syndrom

Clinical Trial

2020 Nov 7;41(42):4114-4123.

JOURNAL:Eur Heart J.

Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial

J Tuñón, PG Steg, ODYSSEY OUTCOMES Investigators et al.

4990

Keywords: chronic kidney disease; glomerular filtration rate; Low-density lipoprotein cholesterol; MACE; PCSK9 inhibition

Full Text PDF